Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints
Clinical trial NCT02394730 · COMPLETED
Trial details
- NCT number
- NCT02394730
- Sponsor
- Kirby Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-11-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.